Patents by Inventor Mark Namchuk

Mark Namchuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CAK inhibitors and uses thereof
    Patent number: 7078209
    Abstract: The present invention relates to compounds useful as inhibitors of CAK, compositions thereof. The present invention also relates to methods using the compositions for treating CAK-mediated diseases, such as fungal infections.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: July 18, 2006
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Brian Ledford, Cameron Stuver Moody, Michael Mullican, Mark Namchuk
  • CAK inhibitors and uses thereof
    Publication number: 20030119793
    Abstract: The present invention relates to compounds useful as inhibitors of CAK, compositions thereof. The present invention also relates to methods using the compositions for treating CAK-mediated diseases, such as fungal infections.
    Type: Application
    Filed: June 6, 2002
    Publication date: June 26, 2003
    Inventors: Brian Ledford, Cameron Stuver Moody, Michael Mullican, Mark Namchuk
  • Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
    Patent number: 5998584
    Abstract: The invention provides fragments of GAD.sub.65 that are specifically reactive with at least one class of GAD.sub.65 autoantibody. Most fragments are substantially free of N-terminal amino acids that would otherwise limit solubility. Different fragment contain epitopes for different classes of GAD.sub.65 autoantibodies. The fragments are used in methods of diagnosing and treating insulin dependent diabetes mellitus and stiff man syndrome.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: December 7, 1999
    Assignee: Reagents of the University of California
    Inventors: Steinunn Baekkeskov, Wiltrud Richter, Yuguang Shi, Mark Namchuk, John Kim
  • Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
    Patent number: 5849506
    Abstract: The invention provides fragments of GAD.sub.65 that are specifically reactive with at least one class of GAD.sub.65 autoantibody. Most fragments are substantially free of N-terminal amino acids that would otherwise limit solubility. Different fragment contain epitopes for different classes of GAD.sub.65 autoantibodies. The fragments are used in methods of diagnosing and treating insulin dependent diabetes mellitus and stiff man syndrome.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: December 15, 1998
    Assignee: The Regents of the University of California
    Inventors: Steinunn Baekkeskov, Wiltrud Richter, Yuguang Shi, Mark Namchuk, John Kim
  • Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
    Patent number: 5691448
    Abstract: The invention provides fragments of GAD.sub.65 that are specifically reactive with at least one class of GAD.sub.65 autoantibody. Most fragments are substantially free of N-terminal amino acids that would otherwise limit solubility. Different fragment contain epitopes for different classes of GAD.sub.65 autoantibodies. The fragments are used in methods of diagnosing and treating insulin dependent diabetes mellitus and stiff man syndrome.
    Type: Grant
    Filed: December 2, 1993
    Date of Patent: November 25, 1997
    Inventors: Steinunn Baekkeskov, Wiltrud Richter, Yuguang Shi, Mark Namchuk, John Kim